Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pmlive.com/pharma_news/nice_recommends_chiesis_elfabrio_for_adults_with_fabry_disease_1497865

PM LIVE
05 Sep 2023

https://www.ema.europa.eu/en/documents/overview/elfabrio-epar-medicine-overview_en.pdf

EMA
25 May 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761161

FDA
09 May 2023

https://www.pharmatimes.com/news/protalix_and_chiesi_gain_positive_opinion_for_pegunigalsidase_alfa_1488829

John Pinching PHARMATIMES
06 Mar 2023
CHMP recommends first pegylated enzyme for Fabry disease
CHMP recommends first pegylated enzyme for Fabry disease

27 Feb 2023

// EUROPEAN PHARMACEUTICAL REVIEW

https://www.europeanpharmaceuticalreview.com/news/179980/chmp-recommends-first-pegylated-enzyme-for-fabry-disease/

EUROPEAN PHARMACEUTICAL REVIEW
27 Feb 2023

https://www.biospace.com/article/releases/chiesi-global-rare-diseases-and-protalix-biotherapeutics-receive-positive-chmp-opinion-for-pegunigalsidase-alfa-for-treatment-of-fabry-disease/

BIOSPACE
25 Feb 2023